Oliver JE, Silman AJ: What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases. Arthritis Research & Therapy. 2009, 11: 223-10.1186/ar2575.
Google Scholar
Pedersen JK, Svendsen AJ, Horslev-Petersen K: Incidence of rheumatoid arthritis in the southern part of Denmark from 1995 to 2001. Open Rheumatol J. 2007, 1: 18-23.
PubMed Central
PubMed
Google Scholar
Kaipiainen-Seppanen O, Kautiainen H: Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980–2000. J Rheumatol. 2006, 33: 2132-2138.
PubMed
Google Scholar
Garcia Rodriguez LA, Tolosa LB, Ruigomez A, Johansson S, Wallander MA: Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol. 2008
Google Scholar
Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K: Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int. 2009, 29: 411-415. 10.1007/s00296-008-0713-6.
PubMed
Google Scholar
Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW: Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med. 2008, 168: 1664-1670. 10.1001/archinte.168.15.1664.
PubMed Central
PubMed
Google Scholar
Maradit Kremers H, Gabriel S: Epidemiology of the rheumatic diseases. Kelley's Textbook of Rheumatology. Edited by: Harris ED Jr. 2005, Philadelphia, PA: Elsevier Saunders, 407-425. 7
Google Scholar
Alamanos Y, Voulgari PV, Drosos AA: Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006, 36: 182-188. 10.1016/j.semarthrit.2006.08.006.
PubMed
Google Scholar
Doran MF, Pond GR, Crowson CS, O'Fallon WM, Gabriel SE: Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002, 46: 625-631. 10.1002/art.509.
PubMed
Google Scholar
Gabriel SE, Crowson CS, Maradit Kremers H, Therneau TM: The rising incidence of rheumatoid arthritis [abstract]. Arthritis Rheum. 2008, 58: S453-10.1002/art.23280.
Google Scholar
Boyer GS, Benevolenskaya LI, Templin DW, Erdesz S, Bowler A, Alexeeva LI, Goring WP, Krylov MY, Mylov NM: Prevalence of rheumatoid arthritis in circumpolar native populations. J Rheumatol. 1998, 25: 23-29.
CAS
PubMed
Google Scholar
Cimmino MA: Prevalence of rheumatoid arthritis in Italy: the Chiavari study. Ann Rheum Dis. 1998, 57: 315-318. 10.1136/ard.57.5.315.
PubMed Central
CAS
PubMed
Google Scholar
Jacobsson LTH, Hanson RL, Knowler WC, Pillemer S, Pettitt DJ, McCance DR, Bennett PH: Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum. 1994, 37: 1158-1165. 10.1002/art.1780370808.
CAS
PubMed
Google Scholar
Saraux A, Guedes C, Allain J, Devauchelle V, Valls I, Lamour A, Guillemin F, Youinou P, Le Goff P: Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. J Rheumatol. 1999, 26: 2622-2627.
CAS
PubMed
Google Scholar
Simonsson M, Bergman S, Jacobsson LT, Petersson IF, Svensson B: The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol. 1999, 28: 340-343. 10.1080/03009749950155319.
CAS
PubMed
Google Scholar
Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L: The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatology (Oxford). 2008, 47: 1088-1092. 10.1093/rheumatology/ken205.
CAS
Google Scholar
Riise T, Jacobsen BK, Gran JT: Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol. 2000, 27: 1386-1389.
CAS
PubMed
Google Scholar
Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, Scott D, Silman A: The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford). 2002, 41: 793-800. 10.1093/rheumatology/41.7.793.
CAS
Google Scholar
Gabriel SE, Crowson CS, O'Fallon WM: Mortality in rheumatoid arthritis: have we made an impact in 4 decades?. J Rheumatol. 1999, 26: 2529-2533.
CAS
PubMed
Google Scholar
Kvalvik AG, Jones MA, Symmons DP: Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol. 2000, 29: 29-37. 10.1080/030097400750001770.
CAS
PubMed
Google Scholar
Krause D, Schleusser B, Herborn G, Rau R: Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum. 2000, 43: 14-21. 10.1002/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7.
CAS
PubMed
Google Scholar
Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E: Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol. 2001, 20: 123-127. 10.1007/PL00011191.
CAS
PubMed
Google Scholar
Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, Dixey J: Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007, 46: 350-357. 10.1093/rheumatology/kel253.
CAS
Google Scholar
Sacks JJ, Helmick CG, Langmaid G: Deaths from arthritis and other rheumatic conditions, United States, 1979–1998. J Rheumatol. 2004, 31: 1823-1828.
PubMed
Google Scholar
Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM, Therneau TM, Roger VL, Gabriel SE: The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007, 56: 3583-3587. 10.1002/art.22979.
PubMed
Google Scholar
Ward MM: Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?. Arthritis Rheum. 2001, 44: 1467-1469. 10.1002/1529-0131(200106)44:6<1467::AID-ART243>3.0.CO;2-6.
CAS
PubMed
Google Scholar
Ziadé N, Jougla E, Coste J: Population-level influence of rheumatoid arthritis on mortality and recent trends: a multiple cause-of-death analysis in France, 1970–2002. J Rheumatol. 2008, 35: 1950-1957.
PubMed
Google Scholar
Jacobsson LT, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T, Geborek P: Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 670-675. 10.1136/ard.2006.062497.
PubMed Central
PubMed
Google Scholar
Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002, 359: 1173-1177. 10.1016/S0140-6736(02)08213-2.
CAS
PubMed
Google Scholar
Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DPM: Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. 2002, 46: 2010-2019. 10.1002/art.10419.
PubMed
Google Scholar
Soderlin MK, Nieminen P, Hakala M: Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol. 1998, 25: 1895-1899.
CAS
PubMed
Google Scholar
Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S: Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999, 26: 2562-2571.
CAS
PubMed
Google Scholar
Gabriel SE, Crowson CS, Maradit Kremers H, Doran MF, Turesson C, O'Fallon WM, Matteson E: Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003, 48: 54-58. 10.1002/art.10705.
PubMed
Google Scholar
Oen KG, Cheang M: Epidemiology of chronic arthritis in childhood. Semin Arthritis Rheum. 1996, 26: 575-591. 10.1016/S0049-0172(96)80009-6.
CAS
PubMed
Google Scholar
von Koskull S, Truckenbrodt H, Holle R, Hormann A: Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective study. Ann Rheum Dis. 2001, 60: 940-945. 10.1136/ard.60.10.940.
PubMed Central
CAS
PubMed
Google Scholar
Kaipiainen-Seppanen O, Savolainen A: Changes in the incidence of juvenile rheumatoid arthritis in Finland. Rheumatology. 2001, 40: 928-932. 10.1093/rheumatology/40.8.928.
CAS
PubMed
Google Scholar
Andersson-Gäre B: Juvenile arthritis – who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol. 1999, 17: 367-374.
PubMed
Google Scholar
Prahalad S, Ryan MH, Shear ES, Thompson SD, Giannini EH, Glass DN: Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum. 2000, 43: 2335-2338. 10.1002/1529-0131(200010)43:10<2335::AID-ANR22>3.0.CO;2-W.
CAS
PubMed
Google Scholar
Forre O, Smerdel A: Genetic epidemiology of juvenile idiopathic arthritis. Scand J Rheumatol. 2002, 31: 123-128. 10.1080/713798345.
PubMed
Google Scholar
Oen K, Fast M, Postl B: Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975–92: cycles in incidence. J Rheumatol. 1995, 22: 745-750.
CAS
PubMed
Google Scholar
Gare BA, Fasth A: Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective study. Pediatrics. 1992, 90: 950-958.
CAS
PubMed
Google Scholar
Peterson LS, Mason T, Nelson AM, O'Fallon WM, Gabriel SE: Juvenile rheumatoid arthritis in Rochester, Minnesota 1960–1993. Arthritis Rheum. 1996, 39: 1385-1390. 10.1002/art.1780390817.
CAS
PubMed
Google Scholar
Peterson LS, Mason T, Nelson AM, O'Fallon WM, Gabriel SE: Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis Rheum. 1997, 40: 2235-2240. 10.1002/art.1780401219.
CAS
PubMed
Google Scholar
Ruperto N, Levinson J, Ravelli A, Shear E, Link Tague B, Murray K, Martini A, Giannini E: Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol. 1997, 24: 945-951.
CAS
PubMed
Google Scholar
Zak M, Pedersen FK: Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology. 2000, 39: 198-204. 10.1093/rheumatology/39.2.198.
CAS
PubMed
Google Scholar
French AR, Mason T, Nelson AM, O'Fallon WM, Gabriel SE: Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study. Arthritis Rheum. 2001, 44: 523-527. 10.1002/1529-0131(200103)44:3<523::AID-ANR99>3.0.CO;2-1.
CAS
PubMed
Google Scholar
Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, Zink A: Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002, 46: 2392-2401. 10.1002/art.10444.
PubMed
Google Scholar
Soderlin MK, Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M: Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis. 2002, 61: 911-915. 10.1136/ard.61.10.911.
PubMed Central
CAS
PubMed
Google Scholar
Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE: The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol. 2000, 27: 1247-1250.
CAS
PubMed
Google Scholar
Harrison BJ, Silman AJ, Barrett EM, Scott DG, Symmons DP: Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol. 1997, 24: 1744-1749.
CAS
PubMed
Google Scholar
Kaipiainen-Seppanen O, Aho K: Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol. 2000, 27: 94-100.
CAS
PubMed
Google Scholar
Gladman DD, Farewell VT, Wong K, Husted J: Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum. 1998, 41: 1103-1110. 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N.
CAS
PubMed
Google Scholar
Wong K, Gladman DD, Husted J, Long JA, Farewell VT: Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum. 1997, 40: 1868-1872. 10.1002/art.1780401021.
CAS
PubMed
Google Scholar
Husted JA, Gladman DD, Farewell VT, Cook RJ: Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001, 45: 151-158. 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T.
CAS
PubMed
Google Scholar
Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Maradit Kremers H: Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol. 2009, 36: 361-367.
PubMed Central
PubMed
Google Scholar
Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM: Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995, 38: 1134-1141. 10.1002/art.1780380817.
CAS
PubMed
Google Scholar
Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM: Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008, 59: 1207-1213. 10.1002/art.24021.
PubMed Central
PubMed
Google Scholar
Felson DT, Zhang Y: An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998, 41: 1343-1355. 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9.
CAS
PubMed
Google Scholar
Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F, National Arthritis Data Work-group: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008, 58: 26-35. 10.1002/art.23176.
PubMed Central
PubMed
Google Scholar
Gabriel SE, Crowson CS, Campion ME, O'Fallon WM: Direct medical costs unique to people with arthritis. J Rheumatol. 1997, 24: 719-725.
CAS
PubMed
Google Scholar
Gabriel SE, Crowson CS, Campion ME, O'Fallon WM: Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol. 1997, 24: 43-48.
CAS
PubMed
Google Scholar
Agency for Healthcare Research and Quality National and regional statistics in the national inpatient sample. [http://www.hcup-us.ahrq.gov/reports/statbriefs/sb34.jsp]
Yelin E: The economics of osteoarthritis. Osteoarthritis. Edited by: Brandt K, Doherty M, Lohmander LS. 1998, New York, NY: Oxford University Press, 23-30.
Google Scholar
Uramoto KM, Michet CJJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE: Trends in the incidence and mortality of systemic lupus erythematosus (SLE) – 1950–1992. Arthritis Rheum. 1999, 42: 46-50. 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2.
CAS
PubMed
Google Scholar
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998, 41: 778-799. 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V.
CAS
PubMed
Google Scholar
Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B, Wigley FM: Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus. 1995, 4: 454-456. 10.1177/096120339500400606.
CAS
PubMed
Google Scholar
Ward MM, Pyun E, Studenski S: Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995, 38: 274-283. 10.1002/art.1780380218.
CAS
PubMed
Google Scholar
Walsh SJ, DeChello LM: Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus. 2001, 10: 637-646. 10.1191/096120301682430230.
CAS
PubMed
Google Scholar
Wang F, Wang CL, Tan CT, Manivasagar M: Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus. 1997, 6: 248-253. 10.1177/096120339700600306.
CAS
PubMed
Google Scholar
Xie SK, Feng SF, Fu H: Long term follow-up of patients with systemic lupus erythematosus. J Dermatol. 1998, 25: 367-373.
CAS
PubMed
Google Scholar
Salvarani C, Cantini F, Boiardi L, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002, 347: 261-271. 10.1056/NEJMra011913.
PubMed
Google Scholar
Baldursson O, Steinsson K, Bjornsson J, Lie JT: Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 1994, 37: 1007-1012. 10.1002/art.1780370705.
CAS
PubMed
Google Scholar
Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG: The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995, 123: 192-194.
CAS
PubMed
Google Scholar
Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE: Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002, 29: 1694-1697.
PubMed
Google Scholar
Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE: The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol. 1999, 26: 1326-1332.
CAS
PubMed
Google Scholar
Nordborg E, Bengtsson B: Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med Res. 1990, 227: 233-236.
CAS
Google Scholar
Machado EBV, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, O'Fallon WM: Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota: 1950–1985. Arthritis Rheum. 1988, 31: 745-749. 10.1002/art.1780310607.
CAS
PubMed
Google Scholar
Hall AP, Barry PE, Dawber TR, McNamara PM: Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med. 1967, 42: 27-37. 10.1016/0002-9343(67)90004-6.
CAS
PubMed
Google Scholar
Currie WJ: Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis. 1979, 38: 101-106. 10.1136/ard.38.2.101.
PubMed Central
CAS
PubMed
Google Scholar
Harris CM, Lloyd DCEF, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995, 48: 1153-1158. 10.1016/0895-4356(94)00244-K.
CAS
PubMed
Google Scholar
Isomaki H, von Essen R, Ruutsalo HM: Gout, particularly diuretics-induced, is on the increase in Finland. Scand J Rheumatol. 1977, 6: 213-216. 10.3109/03009747709095452.
CAS
PubMed
Google Scholar
Klemp P, Stansfield SA, Castle B, Robertson MC: Gout is on the increase in New Zealand. Ann Rheum Dis. 1997, 56: 22-26. 10.1136/ard.56.1.22.
PubMed Central
CAS
PubMed
Google Scholar
Lin KC, Lin HY, Chou P: Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol. 2000, 27: 1045-1050.
CAS
PubMed
Google Scholar
Chang HY, Pan WH, Yeh WT, Tsai KS: Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol. 2001, 28: 1640-1646.
CAS
PubMed
Google Scholar
Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC: Incidence and risk factors for gout in white men. JAMA. 1991, 266: 3004-3007. 10.1001/jama.266.21.3004.
CAS
PubMed
Google Scholar
Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G: Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008, 67: 960-966. 10.1136/ard.2007.076232.
PubMed Central
CAS
PubMed
Google Scholar
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Saag KG: Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis. 2005, 64: 267-272. 10.1136/ard.2004.024091.
PubMed Central
CAS
PubMed
Google Scholar
Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC: Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001, 76: 593-599. 10.4065/76.6.593.
CAS
PubMed
Google Scholar
Haugen AJ, Peen E, Hulten B, Johannessen AC, Brun JG, Halse AK, Haga HJ: Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol. 2008, 37: 30-34. 10.1080/03009740701678712.
CAS
PubMed
Google Scholar
Bjerrum KB: Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997, 75: 281-286.
CAS
PubMed
Google Scholar
Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, Li XC, Dong Y: Prevalence of primary Sjogren's syndrome in China. J Rheumatol. 1995, 22: 659-661.
CAS
PubMed
Google Scholar
Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA: Epidemiology of primary Sjogren's syndrome in Northwest Greece, 1982–2003. Rheumatology (Oxford). 2006, 45: 187-191. 10.1093/rheumatology/kei107.
CAS
Google Scholar
Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, Egrilmez S, Akalin T: The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006, 35: 379-383. 10.1080/03009740600759704.
CAS
PubMed
Google Scholar
Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T: Prevalence of Sjogren's syndrome in Slovenia. Rheumatology. 1999, 38: 164-170. 10.1093/rheumatology/38.2.164.
CAS
PubMed
Google Scholar
Carbone LD, Cooper C, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJD: Ankylosing spondylitis in Rochester, Minnesota, 1935–1989. Is the epidemiology changing?. Arthritis Rheum. 1992, 35: 1476-1482. 10.1002/art.1780351211.
CAS
PubMed
Google Scholar
Kaipiainen-Seppanen O, Aho K, Heliovaara M: Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol. 1997, 24: 496-499.
CAS
PubMed
Google Scholar
Bakland G, Nossent HC, Gran JT: Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum. 2005, 53: 850-855. 10.1002/art.21577.
PubMed
Google Scholar
Alamanos Y, Papadopoulos N, Voulgari P, Karakatsanis A, Siozos C, Drosos A: Epidemiology of ankylosing spondylitis in Northwest Greece, 1983–2002. Rheumatology (Oxford). 2002, 43: 615-618. 10.1093/rheumatology/keh133.
Google Scholar
Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, Makino H, Shibata T, Shingu M, Sakou T, Shichikawa K: Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001, 28: 554-559.
CAS
PubMed
Google Scholar
De Angelis R, Salaffi F, Grassi W: Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol. 2007, 36: 14-21. 10.1080/03009740600904243.
CAS
PubMed
Google Scholar
Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, Juvin R, Behier JM, Fautrel B, Masson C, Coste J: Prevalence of spondyloarthropathies in France. Ann Rheum Dis. 2005, 64: 1431-1435. 10.1136/ard.2004.029207.
PubMed Central
CAS
PubMed
Google Scholar
Lawrence RC, Everett DF, Benevolenskaya LI, Boyer GS, Erdesz S, Templin DW, Alexeeva LI, Lanier AP, Krylov MYu, Cornoni-Huntley JC, Mylov NM, Heyse S: Spondyloarthropathies in circumpolar populations: I. Design and methods of United States and Russian studies. Arctic Med Res. 1996, 55: 187-194.
CAS
PubMed
Google Scholar
Benevolenskaya LI, Boyer GS, Erdesz S, Templin DW, Alexeeva LI, Lawrence RC, Heyse SP, Krylov MY, Mylov NM, Cornoni-Huntley JC, Everett DF, Goring WP, Bowler A: Spondylarthropathic diseases in indigenous circumpolar populations of Russia and Alaska. Rev Rhum Engl Ed. 1996, 63: 815-822.
CAS
PubMed
Google Scholar
Wolfe F, Michaud K: The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis. Arthritis Rheum. 2008, 58: 2612-2621. 10.1002/art.23811.
PubMed
Google Scholar
Michaud K, Wolfe F: Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007, 21: 885-906. 10.1016/j.berh.2007.06.002.
PubMed
Google Scholar
Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE: How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?. Arthritis Rheum. 2005, 52: 3039-3044. 10.1002/art.21349.
PubMed
Google Scholar
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005, 52: 722-732. 10.1002/art.20878.
PubMed
Google Scholar
Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum. 2005, 52: 402-411. 10.1002/art.20853.
PubMed
Google Scholar
Watson D, Rhodes T, Guess H: All-cause mortality and vascular events among patients with RA, OA, or no arthritis in the UK General Practice Research Database. J Rheumatol. 2003, 30: 1196-1202.
PubMed
Google Scholar
Wolfe F, Freundlich B, Straus WL: Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003, 30: 36-40.
PubMed
Google Scholar
Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003, 107: 1303-1307. 10.1161/01.CIR.0000054612.26458.B2.
PubMed
Google Scholar
Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR: Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 2004, 93: 198-200. 10.1016/j.amjcard.2003.09.037.
PubMed
Google Scholar
Sodergren A, Stegmayr B, Lundberg V, Ohman ML, Wallberg-Jonsson S: Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 263-266. 10.1136/ard.2006.052456.
PubMed Central
PubMed
Google Scholar
Turesson C, Jarenros A, Jacobsson L: Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis. 2004, 63: 952-955. 10.1136/ard.2003.018101.
PubMed Central
CAS
PubMed
Google Scholar
del Rincon ID: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001, 44: 2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#.
CAS
PubMed
Google Scholar
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847.
CAS
PubMed
Google Scholar
Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE: The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005, 52: 412-420. 10.1002/art.20855.
PubMed
Google Scholar
Davis JM, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE: The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008, 58: 2603-2611. 10.1002/art.23798.
PubMed Central
PubMed
Google Scholar
Corrao S, Salli L, Arnone S, Scaglione R, Pinto A, Licata G: Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clinical Invest. 1996, 26: 293-297. 10.1046/j.1365-2362.1996.133284.x.
CAS
Google Scholar
Di Franco M, Paradiso M, Mammarella A, Paoletti V, Labbadia G, Coppotelli L, Taccari E, Musca A: Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis. 2000, 59: 227-229. 10.1136/ard.59.3.227.
CAS
PubMed
Google Scholar
Mustonen J, Laakso M, Hirvonen T, Mutru O, Pirnes M, Vainio P, Kuikka JT, Rautio P, Lansimies E: Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest. 1993, 23: 246-253. 10.1111/j.1365-2362.1993.tb00769.x.
CAS
PubMed
Google Scholar
Smitten AL, Simon TA, Hochberg MC, Suissa S: A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther. 2008, 10: R45-10.1186/ar2404.
PubMed Central
PubMed
Google Scholar
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L: Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006, 54: 692-701. 10.1002/art.21675.
PubMed
Google Scholar
Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH: A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 1999, 42: 910-917. 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D.
CAS
PubMed
Google Scholar
Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS, Burma M, Folsom AR, Saag KG: Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med. 2002, 112: 465-471. 10.1016/S0002-9343(02)01051-3.
PubMed
Google Scholar
Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S: Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2009
Google Scholar
James WH: Hypothesis: gonadal hormones act as confounders in epidemiological studies of the associations between some behavioural risk factors and some pathological conditions. J Theor Biol. 2001, 209: 97-102. 10.1006/jtbi.2000.2249.
CAS
PubMed
Google Scholar
Chakravarty EF, Michaud K, Wolfe F: Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol. 2005, 32: 2130-2135.
CAS
PubMed
Google Scholar
Wolfe F, Michaud K: Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum. 2007, 56: 2886-2895. 10.1002/art.22864.
PubMed
Google Scholar
Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR: Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001, 56: 622-627. 10.1136/thorax.56.8.622.
PubMed Central
CAS
PubMed
Google Scholar
Wolfe F, Caplan L, Michaud K: Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol. 2007, 36: 172-178. 10.1080/03009740601153774.
CAS
PubMed
Google Scholar
Fewins HE, McGowan I, Whitehouse GH, Williams J, Mallya R: High definition computed tomography in rheumatoid arthritis associated pulmonary disease. Br J Rheumatol. 1991, 30: 214-216. 10.1093/rheumatology/30.3.214.
CAS
PubMed
Google Scholar
Gabbay E, Tarala R, Will R, Carroll G, Adler B, Cameron D, Lake FR: Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997, 156: 528-535.
CAS
PubMed
Google Scholar
Cortet B, Perez T, Roux N, Flipo RM, Duquesnoy B, Delcambre B, Remy-Jardin M: Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1997, 56: 596-600. 10.1136/ard.56.10.596.
PubMed Central
CAS
PubMed
Google Scholar
Hakala M: Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest. 1988, 93: 114-118. 10.1378/chest.93.1.114.
CAS
PubMed
Google Scholar
Hubbard R, Venn A: The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology (Oxford). 2002, 41: 676-679. 10.1093/rheumatology/41.6.676.
CAS
Google Scholar
Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, Emoto T, Matsumoto T, Lynch DA: Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004, 232: 81-91. 10.1148/radiol.2321030174.
PubMed
Google Scholar
Shettar SP, Chattopadhyay C, Wolstenholme RJ, Swinson DR: Diffuse alveolitis on a small dose of penicillamine. Br J Rheumatol. 1984, 23: 220-224. 10.1093/rheumatology/23.3.220.
CAS
PubMed
Google Scholar
Wolfe F, Schurle DR, Lin JJ, Polland SM, Smith TW, Montgomery-Short R, James DL: Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis. J Rheumatol. 1983, 10: 406-410.
CAS
PubMed
Google Scholar
Ulubas B, Sahin G, Ozer C, Aydin O, Ozgur E, Apaydin D: Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis. Clin Rheumatol. 2004, 23: 249-251. 10.1007/s10067-003-0848-5.
PubMed
Google Scholar
Alarcón GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR, St Clair EW, Sundy JS, Alexander RW, Smith GJ, Axiotis CA: Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med. 1997, 127: 356-364.
PubMed
Google Scholar
Cannon GW: Methotrexate pulmonary toxicity. Rheum Dis Clin North Am. 1997, 23: 917-937. 10.1016/S0889-857X(05)70366-5.
CAS
PubMed
Google Scholar
Green L, Schattner A, Berkenstadt H: Severe reversible interstitial pneumonitis induced by low dose methotrexate: report of a case and review of the literature. J Rheumatol. 1988, 15: 110-112.
CAS
PubMed
Google Scholar
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006, 295: 2275-2285. 10.1001/jama.295.19.2275.
CAS
PubMed
Google Scholar
Madhusudan S, Foster M, Muthuramalingam SR, Braybrooke JP, Wilner S, Kaur K, Han C, Hoare S, Balkwill F, Talbot DC, Ganesan TS, Harris AL: A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res. 2004, 10: 6528-6534. 10.1158/1078-0432.CCR-04-0730.
CAS
PubMed
Google Scholar
Scott DL: Interstitial lung disease and disease modifying antirheumatic drugs. Lancet. 2004, 363: 1239-1240. 10.1016/S0140-6736(04)15969-2.
PubMed
Google Scholar
Chatterjee S: Severe interstitial pneumonitis associated with infliximab therapy. Scand J Rheumatol. 2004, 33: 276-277. 10.1080/03009740410005836.
CAS
PubMed
Google Scholar
Kramer N, Chuzhin Y, Kaufman LD, Ritter JM, Rosenstein ED: Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum. 2002, 47: 670-671. 10.1002/art.10803.
PubMed
Google Scholar
Doran M, Crowson C, Pond G, O'Fallon W, Gabriel S: Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002, 46: 2287-2293. 10.1002/art.10524.
PubMed
Google Scholar
Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM: Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum. 2008, 59: 1074-1081. 10.1002/art.23913.
PubMed
Google Scholar
Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH: Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007, 56: 1754-1764. 10.1002/art.22600.
CAS
PubMed
Google Scholar
Symmons DP: Mortality in rheumatoid arthritis. Br J Rheumatol. 1988, 27 (suppl 1): 44-54.
PubMed
Google Scholar
Allebeck P: Increased mortality in rheumatoid arthritis. Scand J Rheumatol. 1982, 11: 81-86. 10.3109/03009748209098167.
CAS
PubMed
Google Scholar
Koota K, Isomake H, Mutru O: Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol. 1977, 6: 241-244. 10.3109/03009747709095458.
CAS
PubMed
Google Scholar
Isomaki HA, Mutru O, Koota K: Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol. 1975, 4: 205-208.
CAS
PubMed
Google Scholar
Franklin J, Lunt M, Bunn D, Symmons D, Silman A: Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis. 2007, 66: 308-312. 10.1136/ard.2006.057265.
PubMed Central
PubMed
Google Scholar
Salliot C, Gossec L, Ruyssen-Witrand A, Luc M, Duclos M, Guignard S, Dougados M: Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. Rheumatology (Oxford). 2007, 46: 327-334. 10.1093/rheumatology/kel236.
CAS
Google Scholar
Wolfe F, Caplan L, Michaud K: Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum. 2006, 54: 628-634. 10.1002/art.21568.
CAS
PubMed
Google Scholar
Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, Shatin D, Saag KG: Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum. 2007, 56: 1125-1133. 10.1002/art.22504.
CAS
PubMed
Google Scholar
Costenbader KH, Glass R, Cui J, Shadick N: Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. JAMA. 2006, 296: 2201-10.1001/jama.296.18.2201-a. author reply 2203–2204.
CAS
PubMed
Google Scholar
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP: Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006, 54: 2368-2376. 10.1002/art.21978.
CAS
PubMed
Google Scholar
Brassard P, Lowe AM, Bernatsky S, Kezouh A, Suissa S: Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum. 2009, 61: 300-304. 10.1002/art.24476.
PubMed
Google Scholar
Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R: Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol. 2003, 30: 1436-1439.
PubMed
Google Scholar
Brassard P, Kezouh A, Suissa S: Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2006, 43: 717-722. 10.1086/506935.
CAS
PubMed
Google Scholar
Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC: Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol. 2007, 34: 706-711.
CAS
PubMed
Google Scholar
Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Romanus V, Klareskog L, Feltelius N: Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum. 2005, 52: 1986-1992. 10.1002/art.21137.
CAS
PubMed
Google Scholar
Winthrop KL, Siegel JN, Jereb J, Taylor Z, Iademarco MF: Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum. 2005, 52: 2968-2974. 10.1002/art.21382.
CAS
PubMed
Google Scholar
Wolfe F, Michaud K, Anderson J, Urbansky K: Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum. 2004, 50: 372-379. 10.1002/art.20009.
CAS
PubMed
Google Scholar
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001, 345: 1098-1104. 10.1056/NEJMoa011110.
CAS
PubMed
Google Scholar
Jick SS, Lieberman ES, Rahman MU, Choi HK: Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006, 55: 19-26. 10.1002/art.21705.
PubMed
Google Scholar
Sichletidis L, Settas L, Spyratos D, Chloros D, Patakas D: Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis. 2006, 10: 1127-1132.
CAS
PubMed
Google Scholar
Gomez-Reino JJ, Carmona L, Angel Descalzo M: Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum. 2007, 57: 756-761. 10.1002/art.22768.
CAS
PubMed
Google Scholar
Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA: The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007, 57: 1431-1438. 10.1002/art.23112.
PubMed
Google Scholar
Wolfe F, Michaud K, Chakravarty EF: Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford). 2006, 45: 1370-1375. 10.1093/rheumatology/kel328.
CAS
Google Scholar
Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A: Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009, 301: 737-744. 10.1001/jama.2009.146.
CAS
PubMed
Google Scholar
Garner SE, Fidan DD, Frankish RR, Judd MG, Towheed TE, Wells G, Tugwell P: Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev. 2005, 1: CD003685-
PubMed
Google Scholar
Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999, 340: 1888-1899. 10.1056/NEJM199906173402407.
CAS
PubMed
Google Scholar
Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS: Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999, 282: 1921-1928. 10.1001/jama.282.20.1921.
CAS
PubMed
Google Scholar
Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS: Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 1999, 354: 2106-2111. 10.1016/S0140-6736(99)02332-6.
CAS
PubMed
Google Scholar
Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, Verburg KM, Geis GS: Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol. 2000, 95: 1681-1690. 10.1111/j.1572-0241.2000.02194.x.
CAS
PubMed
Google Scholar
Langman M, Jensen DM, Watson DJ, Harper SE, Zhao PL, Quan H, Bolognese JA, Simon TJ: Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA. 1999, 282: 1929-1933. 10.1001/jama.282.20.1929.
CAS
PubMed
Google Scholar
MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG: Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ. 1997, 315: 1333-1337.
PubMed Central
CAS
PubMed
Google Scholar
Garcia Rodriguez LA, Hernandez-Diaz S: The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen and combinations of these agents. Arthritis Res. 2001, 3: 98-101. 10.1186/ar146.
PubMed Central
CAS
PubMed
Google Scholar
Wolfe F, Michaud K: Anemia and renal function in patients with rheumatoid arthritis. J Rheumatol. 2006, 33: 1516-1522.
PubMed
Google Scholar
Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK: Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000, 43: 522-530. 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y.
CAS
PubMed
Google Scholar
van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C: Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006, 54: 3104-3112. 10.1002/art.22117.
CAS
PubMed
Google Scholar
Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC: Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1995, 10: 257-263.
CAS
PubMed
Google Scholar
Kroger H, Honkanen R, Saarikoski S, Alhava E: Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis: a population based study. Ann Rheum Dis. 1994, 53: 18-23. 10.1136/ard.53.1.18.
PubMed Central
CAS
PubMed
Google Scholar
Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S: A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol. 2000, 27: 2582-2589.
CAS
PubMed
Google Scholar
Solomon DH, Katz JN, Cabral D, Patrick AR, Bukowski JF, Coblyn JS: Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement. Arthritis Rheum. 2006, 55: 873-877. 10.1002/art.22350.
CAS
PubMed
Google Scholar
Hawley DJ, Wolfe F: Depression is not more common in rheumatoid arthritis: a 10-year longitudinal study of 6,153 patients with rheumatic disease. J Rheumatol. 1993, 20: 2025-2031.
CAS
PubMed
Google Scholar
Ang DC, Choi H, Kroenke K, Wolfe F: Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005, 32: 1013-1019.
PubMed
Google Scholar